Thromboembolic events following brachytherapy: Case reports

Journal of Contemporary Brachytherapy

Volumn 7, Issue 1, 2015, Pages 76-78

  Guy, Jean Baptiste ^a   Falk, Alexander Tuan ^b   Chargari, Cyrus ^c   Bertoletti, Laurent ^d,e   Magné, Nicolas ^a  

^a Lucien Neuwirth Cancer Institute   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c University of Paris Descartes   (France)

^d UNIVERSITÉ JEAN MONNET   (France)

^e UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Brachytherapy; Endometrial cancer; Pulmonary embolism; Thromboembolic events.

Indexed keywords

ANTIVITAMIN K; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DOPPLER FLOWMETRY; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; LUNG EMBOLISM; MIDDLE AGED; PULMONARY HYPERTENSION; PULSED DOSE RATE BRACHYTHERAPY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84924871568     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2015.48580     Document Type: Article

References (17)

1. Eldredge-Hindy HB, Eastwick G, Anne PR et al. Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer. J Contemp Brachytherapy 2014; 6: 262-270.
2. Van der Steen-Banasik E. Primary brachytherapy as a radical treatment for endometrial carcinoma. J Contemp Brachytherapy 2014; 6: 106-112.
3. Chargari C, Magné N, Dumas I et al. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys 2009; 74: 133-139.
4. Donnelly ED, Rakhra S, Helenowski I et al. Dosimetry and to-xicity outcomes in postoperative high-dose-rate intracavitary brachytherapy for endometrial carcinoma. J Contemp Brachy-therapy 2012; 4: 135-140.
5. Duru S, Keleşoglu A, Ardiç S. Clinical update on pulmonary embolism. Arch Med Sci 2014; 10: 557-565.
6. Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 2009; 27: 4839-4847.
7. Verheij M, Dewit LG, Boomgaard MN et al. Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Willebrand factor. Radiat Res 1994; 137: 202-207.
8. Chao CK, Grigsby PW, Perez CA et al. Brachytherapy-related complications for medically inoperable stage I endometrial carcinoma. Int J Radiat Oncol Biol Phys 1995; 31: 37-42.
9. Jhingran A, Eifel PJ. Perioperative and postoperative complications of intracavitary radiation for FIGO stage I-III carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000; 46: 1177-1183.
10. Heit JA, Silverstein MD, Mohr DN et al. Risk factors for deep vein thrombosis and pulmonary embolism: a popu-lation-based case-control study. Arch Intern Med 2000; 160: 809-815.
11. Khorana AA, Francis CW, Culakova E et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost JTH 2007; 5: 632-634.
12. Blom JW, Osanto S, Rosendaal FR. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost JTH 2004; 2: 1760-1765.
13. Dusenbery KE, Carson LF, Potish RA. Perioperative morbidity and mortality of gynecologic brachytherapy. Cancer 1991; 67: 2786-2790.
14. Peedicayil A, Weaver A, Li X et al. Incidence and timing of venous thromboembolism after surgery for gynecological cancer. Gynecol Oncol 2011; 121: 64-69.
15. Farge D, Debourdeau P, Beckers M et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost JTH 2013; 11: 56-70.
16. Hill J, Treasure T. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline. Heart 2010; 96: 879-882.
17. Lyman GH, Khorana AA, Kuderer NM et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31: 2189-2204.